Startup Orbis Medicines Launches With €26M for Next-Generation Peptide Drugs
Medcity News,
For all of the benefit that biologic drugs provide as treatments for chronic conditions, these medications also require chronic…
For all of the benefit that biologic drugs provide as treatments for chronic conditions, these medications also require chronic…
Orbis Medicines emerged from stealth Feb. 29 with $28 million in seed funding. The company is the latest launched to turn…
For decades, a substantial number of proteins, vital for treating various diseases, have remained elusive to oral drug therapy.
Scientists at EPFL have developed stable orally available cyclic peptides with a much higher bioavailability than current ones…